Strinacin II
Introduction

Company name: Merial Animal Health Ltd
Address: PO Box 327
Sandringham House
Harlow Business Park
Harlow
Essex CM19 5TG
Telephone: Companion Animals 0870 6000123
Production Animals 0800 592699
Fax: 01279 775888
Email: ukenquiry@merial.com
Website: www.merial.com
Presentation
Pink-coloured, scored, bolus-shaped tablets. Each tablet contains 1.0 g sulphadiazine, 200 mg trimethoprim and amaranth dye (E123) 0.016% w/w.
Uses
STRINACIN II is primarily indicated for the treatment of bacterial scours, but may also be used for the treatment of acute salmonellosis and bacterial pneumonia in calves.
Dosage and administration
Calves
By oral administration. STRINACIN II tablets may be administered whole, by hand or balling gun, or may be dispersed in about 300ml water to be used as an oral drench. The daily dose is one tablet per 40 kg (90 lb) bodyweight, to provide 30 mg of combined active ingredients per kg bodyweight daily. Treatment should be repeated daily until two days after the symptoms have resolved, but in cases of salmonellosis and bacterial pneumonia treatment should be continued for five consecutive days.
Contra-indications, warnings, etc
STRINACIN II should not be used in animals with functionally mature rumens.
For animal treatment only.
Protective gloves should be worn to avoid skin sensitization, which may occur when crushing the bolus of this product.
Wash hands after use.
Avoid direct contact with skin and eyes. If contact occurs, wash affected area with copious amounts of water. Seek medical advice if irritation persists.
Withdrawal periods
Animals must not be slaughtered for human consumption during treatment. Calves may be slaughtered for human consumption only after 15 days from the last treatment.
Pharmaceutical precautions
Store in a dry place. Do not store above 25°C. Protect from light.
Keep out of reach of children.
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Legal category
POM-V
Packaging Quantities
White or grey polypropylene 'securitainers' containing 20 tablets.
Further information
Together, the active ingredients have a broad bactericidal action against many gram-positive and gram-negative aerobic bacteria and a large proportion of anaerobic bacteria.
Marketing authorisation number
Vm 08327/4058.